SLC2A2 and diabetes mellitus: It poses high selectivity by pancreatic beta cells because of their structural similarity to glucose, allowing the STZ to bind to the glucose transporter receptor GLUT2 by accumulating in these cells by initiating an autoimmune process that results in the destruction of the Langerhans islets beta cells with the onset of clinical diabetes within 24–72 h [29,30].